Days Inventory is also known as Days Sales of Inventory (DSI). Biocept's Average Total Inventories for the
three
months ended in Jun. 2023 was $0.63 Mil. Biocept's Cost of Goods Sold for the
three
months ended in Jun. 2023 was $2.55 Mil.
Hence, Biocept's Days Inventory for the
three
months ended in Jun. 2023 was 22.45.
The historical rank and industry rank for Biocept's Days Inventory or its related term are showing as below:
BIOCQ's Days Inventory is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 68.88 * Ranked among companies with meaningful Days Inventory only.
Biocept's Days Inventory
declined
from Jun. 2022 (31.11) to Jun. 2023 (22.45).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Biocept's Inventory Turnover for the
three
months ended in Jun. 2023 was 4.06.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biocept's Inventory-to-Revenue for the
three
months ended in Jun. 2023 was 1.07.
Biocept (OTCPK:BIOCQ) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Biocept's Inventory Turnover for the
three
months ended in Jun. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biocept's Inventory to Revenue for the
three
months ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Biocept Days Inventory Related Terms
Biocept Days Inventory Historical Data
* Premium members only.
The historical data trend for Biocept's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIOCQ vs IDTA, DIGP, ABMC: Days Inventory Comparison
For the Diagnostics & Research subindustry, Biocept's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biocept Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Biocept's Days Inventory distribution charts can be found below:
* The bar in red indicates where Biocept's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biocept (BIOCQ) has a Days Inventory of 22.45 as of Jun. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biocept and its competitors.
Is Biocept's Days Inventory too high?
Biocept's current Days Inventory is 22.45. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Biocept's value of 22.45 is 67.4% below this industry median. Overall, Biocept has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Biocept's Days Inventory compare to IDTA and DIGP?
Biocept's Days Inventory of 22.45 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Inventory is 68.88. Biocept's value of 22.45 is 67.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biocept's current Days Inventory of 22.45 is 67.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biocept and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biocept's current Days Inventory is 22.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biocept stock overvalued right now?
Biocept (BIOCQ) has a current Days Inventory of 22.45. The current Days Inventory is 22.45 and 67.4% below the Medical Diagnostics & Research industry median of 68.88. Biocept's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Biocept (BIOCQ), the current Days Inventory is 22.45 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
16GF Score
Get the complete analysis for BIOCQ
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOCQ has been successfully added to your 
